Comparison

ManageMR vs COAPT Risk Score

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

ManageMR

This medical app offers personalized referral and treatment guidance for mitral regurgitation patients. It analyzes echo assessment parameters to determine MR severity, etiology, and recommend appropriate interventions like valve repair or replacement.

Highlights
  • Personalized referral advice
  • Treatment recommendations
  • MR severity and etiology analysis
  • Mitral valve repair vs. replacement feasibility
  • Echo assessment parameter entry
Features
Read full description

This clinical decision support app provides clinicians with personalized referral and treatment advice for diagnosed mitral regurgitation patients by verifying the severity and etiology of the MR. • Enter patient parameters from an echo assessment. • Review customized advice on - Probable severity and etiology of a patient’s MR - Need for referral - Feasibility of mitral valve repair vs. replacement for the patient Content in this app is derived from the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation. The information and recommendations in this clinical decision support app are not meant to represent the only or best course of care nor replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.

About

COAPT Risk Score

This medical tool calculates a 2-year risk score for death and/or heart failure hospitalization in patients with specific heart conditions. It combines clinical and echocardiographic data to aid in shared decision-making regarding treatment options.

Highlights
  • Risk prediction for death and heart failure hospitalization
  • Calculates 2-year risk score
  • Combines clinical and echocardiographic variables
  • Supports shared decision-making
  • Educational tool for medical professionals
  • Based on COAPT trial data
Features
Read full description

For educational purposes and for use by medical professionals only. For patients with severe functional mitral regurgitation and symptomatic heart failure (left ventricular ejection fraction between 20-50%) despite best medical therapy. The COAPT Risk Score is a simple risk prediction tool created by combining clinical and echocardiographic variables in patients with heart failure (HF) and moderate-to-severe or severe functional mitral regurgitation (FMR) who remain symptomatic despite maximally tolerated guideline directed medical therapy (GDMT). The COAPT Risk Score provides valuable prognostic information regarding the 2-year risk of death and/or heart failure hospitalization (HFH). The score is derived from the COAPT trial population of patients with HF and moderate-to-severe or severe FMR randomized to treatment with either transcatheter edge-to-edge repair (TEER) with MitraClip plus GDMT or GDMT alone. We can incorporate TEER in the risk score and provide updated 2-year risk of death and/or HFH which can serve as a valuable shared decision-making tool for patients and physicians as well as heart teams while deciding about TEER. Created by a team of subject-matter experts including: the director of The Mount Sinai Hospital cardiac cath lab Dr. Kini, Director of Clinical and Interventional Cardiology at the Mount Sinai Health System Dr Sharma, the Mount Sinai Hospital Surgical Director Dr. Tang, COAPT Principal Investigator Dr. Stone, and COAPT Risk Score publication author Dr. Shah.

Screenshots

ManageMR4 screens
COAPT Risk Score4 screens

Verdict

The call

ManageMR and COAPT Risk Score are too close to call on the numbers: across 8 compared parameters — price, rating, ratings volume and ads among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 5.0 for ManageMR against 5.0 for COAPT Risk Score. Both are backed by a comparable volume of ratings — 1 and 1 respectively.

ScorecardNo meaningful differences
ManageMR versus COAPT Risk Score: the parameters behind the verdict, then further details
ParameterManageMRCOAPT Risk Score
PriceFreeFree
Rating5.0 (1 ratings)5.0 (1 ratings)
Number of ratings11
Update frequencyEvery 21 months—
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS13.012.0 — better
Further details — not scored
Size58 MB28 MB
Age rating17+17+
DeveloperAmerican College of CardiologyCardiology Apps LLC

Customer experience

ManageMR

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%

COAPT Risk Score

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

ManageMR

No in-app purchases

None

COAPT Risk Score

No in-app purchases

Questions

Is ManageMR free?
ManageMR is free to download, with no in-app purchases.
Is COAPT Risk Score free?
COAPT Risk Score is free to download, with no in-app purchases.
Which has better reviews, ManageMR or COAPT Risk Score?
ManageMR and COAPT Risk Score are both rated 5.0 out of 5 on the App Store, from 1 and 1 ratings respectively.
Do ManageMR or COAPT Risk Score have ads?
Neither ManageMR nor COAPT Risk Score shows ads.

Other comparisons